Ann Mari Holsæter
Job description
Ann Mari Holsæter is a Associate Professor within the Drug Transport and Delivery (DTD) research group since January 2011
Ann Mari is a pharmacist by background (Cand.Pharm., 1999) and holds a doctoral degree in Pharmaceutics (Dr.Scient, 2004)
Ann Mari Holsæter kept different manager positions in neutraceutical and pharmaceutical companies (ProBio Neutraceuticals AS (2006-2008) og Biotec Pharmacon ASA (2008-2011), and was also approved as QP in this periode.
Error rendering component
Research interests
Her research focus is on advanced (nano)delivery systems, aiming to improve drug therapy through improved uptake, stability and/or specificity, with reduced side-effects and more effective therapy as the main goal. Her expertise and research interest are particularly focused on liposomes, nanofibers and hydrogels, either applied alone or in combination. Drug formulations are intended for topical (wounded skin) or systemic (injection) administration, possessing either antimicrobial, anti-cancer or immunomodulating effect.
In the DTD-research group, Ann Mari is holding a specific expertise in electrospinning of nanofibers and in applying "dual centrifugation" for the homogenization and size reduction of nanoparticle, including mainly liposomes.
Teaching
Teaching responsibilities;
- FAR-2401; Ex tempore production and quality control (10 ECTs), lecturer (previous course responsible, 2012-2019)
- FAR-2402; Drug formulation and biopharmacy (10 ECTs)- course responsible since 2019
- FAR-3401; Advanced Pharmaceutics and biopharmaceutics (10 ECTs), lecturer
- FAR-3911; Master project in pharmacy (pharmaceutics) (50 ECTs), supervisor
- FAR-3402: Advanced drug delivery systems in nanomedicine (10 ECTs), lecturer
- FAR-8402; Nanomedicine and nanotechnology (10 ECTs), lecturer
